UNSPSC 42294304: Minimally invasive breast biopsy marker instruments

In this classification, this commodity indicates a product used as a minimally invasive breast biopsy marker instrument during a surgical procedure in a medical setting. US FDA regulates Minimally invasive breast biopsy marker instruments under 21 CFR 878.43 and under FDA product code FZP. Most nations, for tariff and trade purposes, schedule these products under HS 901890.

UNSPSC 42294304 Minimally invasive breast biopsy marker instruments (Commodity) shows minimal alignment with the recent state and local contracting activity tagged under this code. The five most recent opportunities posted between May and August 2026 span surgical power equipment, operating room laser systems, outpatient building furniture, and law enforcement equipment — none of which are breast biopsy markers or related minimally invasive diagnostic instruments. The code appears to be a mismatch with the actual procurement activity it is receiving, suggesting either miscategorization by issuing bodies or limited recent demand for breast biopsy marker instruments through state and local channels.

The tagged opportunities originate from San Mateo County (San Mateo Medical Center), the State of California, and Sourcewell (a Minnesota cooperative serving multiple states and counties including Washington jurisdictions). None of the solicitations — RFPs for surgical power and laser equipment at SMMC, state RFBs for outpatient furniture in California, and a multi-state cooperative RFP for law enforcement equipment through Sourcewell — correspond to minimally invasive breast biopsy diagnostics. The code shows no recent relevant state or local procurement activity.